01—History
Revenue History
Year-over-year comparison from 10-K annual reports · Dashed line: constant growth FY2020–FY2025. Drag across the bars to change the range.
- $4.02B
02—Ledger
Revenue, period by period
| Period | Scale | Value | Change | Source |
|---|---|---|---|---|
| FY2025 | $4.02B | −0.9% | 10-K | |
| FY2024 | $4.05B | −1.9% | 10-K | |
| FY2023 | $4.13B | +3.9% | 10-K | |
| FY2022 | $3.98B | +12.3% | 10-K | |
| FY2021 | $3.54B | +21.1% | 10-K | |
| FY2020 | $2.92B | +11.5% | 10-K | |
| FY2019 | $2.62B | +15.7% | 10-K | |
| FY2018 | $2.27B | +22.0% | 10-K | |
| FY2017 | $1.86B | +10.5% | 10-K | |
| FY2016 | $1.68B | +23.3% | 10-K | |
| FY2015 | $1.36B | +5.1% | 10-K | |
| FY2014 | $1.30B | +11.3% | 10-K | |
| FY2013 | $1.17B | +3.2% | 10-K | |
| FY2012 | $1.13B | −1.1% | 10-K | |
| FY2011 | $1.14B | +0.8% | 10-K | |
| FY2010 | $1.13B | −3.3% | 10-K | |
| FY2009 | $1.17B | −9.5% | 10-K | |
| FY2008 | $1.30B | — | 10-K |
03—Questions
What is revenue?
Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
What is Charles River Laboratories International's current revenue?
Charles River Laboratories International (CRL) annual revenue for 2025 was $4.02B, a 0.85% decline from 2024. Charles River Laboratories International revenue for the quarter ending September 26, 2026 was $982.7M.
What was Charles River Laboratories International's revenue in 2024?
Charles River Laboratories International annual revenue for 2024 was $4.05B, a 1.92% decline from 2023.
What was Charles River Laboratories International's revenue in 2023?
Charles River Laboratories International annual revenue for 2023 was $4.13B, a 3.86% increase from 2022.
What is Charles River Laboratories International's 5-year revenue CAGR?
Charles River Laboratories International revenue grew at a compound annual growth rate (CAGR) of 6.55% from FY2020 to FY2025, going from $2.92B to $4.02B over 5 years.
- Company
- Charles River Laboratories International
- Ticker
- CRL
- Sector
- Healthcare
- Industry
- Services-Commercial Physical & Biological Research